In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine
- 1 October 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 187 (3) , 399-408
- https://doi.org/10.1016/0014-2999(90)90367-f
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Definition of the In-vivo Accumulation of [3H]spiperone in Brain using Haloperidol and Sulpiride to Determine Functional Dopamine Receptor OccupationJournal of Pharmacy and Pharmacology, 1988
- Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in ratsEuropean Journal of Cancer and Clinical Oncology, 1984
- Correlation between inhibitory effect on prolactin secretion and antitumor activity of new ergoline compounds on DMBA-induced tumors in ratsEuropean Journal of Cancer and Clinical Oncology, 1983
- 434 Antitumor activity of fce 21336, a new prolactin lowering drug, on experimental hormone-responsive tumorsJournal of Steroid Biochemistry, 1983
- Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidolCellular and Molecular Life Sciences, 1981
- Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptorsEuropean Journal of Pharmacology, 1981
- Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium propertiesLife Sciences, 1981
- Antiparkinsonian drug doses and neuroleptic receptorsCellular and Molecular Life Sciences, 1978
- ON THE RELEVANCE OF PREFERENTIAL INCREASES OF MESOLIMBIC VERSUS STRIATAL DOPAMINE TURNOVER FOR THE PREDICTION OF ANTIPSYCHOTIC ACTIVITY OF PSYCHOTROPIC DRUGSJournal of Neurochemistry, 1976
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966